FMP
Bone Therapeutics SA
BOTHE.BR
EURONEXT
Inactive Equity
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.
0.29 EUR
0 (0%)
About
ceo
Dr. Miguel Forte M.D., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.bonetherapeutics.com
exchange
EURONEXT
Description
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.
CIK
N/A
ISIN
BE0974280126
CUSIP
N/A
Address
Rue Granbonpré 11 - Bâtiment H
Phone
32 49 309 73 66
Country
BE
Employee
20
IPO Date
Feb 6, 2015
Summary
CIK
-
Exchange
EURONEXT
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
BE0974280126
Country
BE
Price
0.29
Beta
0.3
Volume Avg.
201.58k
Market Cap
0
Shares
-
52-Week
0.112-1.218
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.38
P/B
-
Website
https://www.bonetherapeutics.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BOTHE.BR News
It looks like there's no news available.
